Analysis of 2023 December China E-cigarette Exports to Switzerland

Industry Insight by 2FIRSTS Mincy
Mar.11.2024
Analysis of 2023 December China E-cigarette Exports to Switzerland
China's e-cigarette exports to Switzerland surged in December 2023, with a 72.18% monthly increase totaling $5.63 million.

According to the latest trade data released by the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export data from China to Switzerland in December 2023. The details are as follows:

Analysis of 2023 December China E-cigarette Exports to Switzerland
Image source: 2FIRSTS (Mincy graphics)

 

The export value reached approximately $5.63 million, showing a month-on-month increase of 72.18% and a year-on-year increase of 32.03%.

Analysis of 2023 December China E-cigarette Exports to Switzerland
Image source: 2FIRSTS (Mincy design)

 

The export volume is approximately 94 tons, an increase of 32.89% month-on-month and 56.90% year-on-year.

Analysis of 2023 December China E-cigarette Exports to Switzerland
Image source: 2FIRSTS (Mincy diagram)

 

The export unit price was $59.49 per kilogram, representing a 29.56% increase month-on-month and a 15.85% decrease year-on-year. The average price for "e-cigarettes and similar personal electronic vaporizing devices" was $13.93 per unit.

 

Analysis of 2023 December China E-cigarette Exports to Switzerland
Image source: 2FIRSTS (Mincy Mapping)

 

Among them, "e-cigarettes and similar personal electronic vaporizer devices" accounted for 38.58% of the export category, while "non-burning products containing nicotine without tobacco or reconstituted tobacco" accounted for 61.42%.

Analysis of 2023 December China E-cigarette Exports to Switzerland
Image source: 2FIRSTS (created by Mincy)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
A former political aide has alleged that a RM50 million bribe was offered to Malaysia’s then health minister to abandon the tobacco generational end game (GEG) policy. The claim was published in an opinion article and on social media. No report was made to anti-corruption authorities. Despite the alleged rejection, the GEG provision was later removed from the tobacco bill tabled in Parliament in 2023.
Dec.23 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan has approved amendments to its tobacco law that introduce a comprehensive ban on e-cigarettes and their components, covering import, export, production, storage, wholesale and retail sales, and use. Nicotine-containing e-cigarettes are classified as tobacco products under the revised framework. The law takes effect on April 1, 2026.
Jan.27 by 2FIRSTS.ai
Breaking News | China Deploys Full-Chain Crackdown on Illicit Tobacco, Enforcement Storm Looms for Illegal Tobacco and E-Cigarettes
Breaking News | China Deploys Full-Chain Crackdown on Illicit Tobacco, Enforcement Storm Looms for Illegal Tobacco and E-Cigarettes
China has issued a high-level directive to crack down on illicit tobacco activities, bringing e-cigarettes and nicotine pouches under tighter enforcement. The move follows a Premier-led meeting and underscores stepped-up oversight across the tobacco supply chain, amid the sector’s continued fiscal importance.
Dec.18